News
Archive
Novadip Biosciences SA announces positive results from Phase 1/2 clinical trial in patients with severe bone non-union of the lower limb following trauma
Ventyx Biosciences announces dosing of the first patient in the Phase 2 SERENITY trial of VTX958 for the treatment of moderate to severe plaque psoriasis
Resolve Therapeutics completes enrollment of Phase II Long Covid clinical trial
Novadip Biosciences raises additional EUR 40 Million bringing total company funding to EUR 88 Million
Phase Four unveils game changing engine for LEO Constellations
Ventyx Biosciences announces positive topline Phase I data for its selective allosteric TYK2 inhibitor VTX958
Back To News
November 13, 2017
10 Predictions For AI, Big Data, And Analytics in 2018
A new Forrester Research report, Predictions 2018: The Honeymoon For AI Is Over, predicts that in 2018 enterprises will finally move beyond the hype to recognize that AI requires hard work—planning, deploying, and governing it correctly. But Forrester also promises improvements: Better human and machine collaboration due to improved interfaces; enhancing business intelligence and analytics solutions … Continue reading “10 Predictions For AI, Big Data, And Analytics in 2018”
The post 10 Predictions For AI, Big Data, And Analytics in 2018 appeared first on Fuzzy Logix.